Polymer nanoassemblies for cancer treatment and imaging

Therapeutic Delivery

Volumn 1, Issue 6, 2010, Pages 803-817

  Lee, Hyun Jin ^a   Ponta, Andrei ^a   Bae, Younsoo ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; COPOLYMER; DOXORUBICIN; DRUG CARRIER; MACROGOL; POLYAMINOACID; POLYASPARAGINE; POLYASPARTIC ACID; POLYMER;

CANCER THERAPY; CONTROLLED DRUG RELEASE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; IN VIVO STUDY; MICELLE; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 79954555827     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.10.70     Document Type: Review

References (79)

1. Stiriba S-E, Kautz H, Frey H. Hyperbranched molecular nanocapsules: comparison of the hyperbranched architecture with the perfect linear analogue. J. Am. Chem. Soc. 124, 9698-9699 (2002).
2. Naira LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 32, 762-798 (2007). (Pubitemid 47198287)
3. Gaucher G, Marchessault RH, Leroux J-C. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Control. Release 143, 2-12 (2010).
4. Deming TJ. Methodologies for preparation of synthetic block copolypeptides: materials with future promise in drug-delivery. Adv. Drug Del. Rev. 54, 1145-1155 (2002).
5. Zhang L, Eisenberg A. Multiple morphologies of crew-cut aggregates of polystyrene-bpoly( acrylic acid) block copolymers. Science 268, 1728-1731 (1995).
6. Putnam D, Kope?ek J. Polymer conjugates with anticancer activity. Adv. Polym. Sci. 122, 55-123 (1995).
7. Webber SE, Munk P, Tuzar Z. Solvents and self-organization of polymers. Kluwer Academic Pub. 327, 383-407 (1996).
8. Van Dongen SFM, De Hoog HPM, Peters RJRW, Nallani M, Nolte RJM, Van Hest JCM. Biohybrid polymer capsules. Chem. Rev. 109, 6212-6274 (2009).
9. Meyer EE, Rosenberg KJ, Israelachvili J. Recent progress in understanding hydrophobic interactions. Proc. Natl Acad. Sci. USA 103, 15739-15746 (2006). (Pubitemid 44657537)
10. Lim YB, Moon KS, Lee M. Rod-coil block molecules: their aqueous self-assembly and biomaterials applications. J. Mater. Chem. 18, 2909-2918 (2008).
11. Israelachvili JN. Intermolecular and Surface Forces: With Applications to Colloidal and Biological Systems (2nd Edition). Academic Press, CA, USA (1992).
12. Smart T, Homas H, Massignani M, Flores-Merino MV, Perez LR, Battaglia G. Block copolymer nanostructures. Nanotoday 3, 38-46 (2008). (Pubitemid 351781283)
13. Cai C, Lin J, Chen T, Tian X. Aggregation behavior of graft copolymer with rigid backbone. Langmuir 26, 2791-2797 (2010).
14. Won Y-Y, Brannan AK, Davis HT, Bates FS. Cryogenic transmission electron microscopy (Cryo-TEM) of micelles and vesicles formed in water by poly(ethylene oxide)-based block copolymers. J. Phys. Chem. B 106, 3354-3364 (2002). (Pubitemid 35290231)
15. Ahmed F, Discher DE. Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. J. Control. Release 96, 37-53 (2004). (Pubitemid 38438488)
16. Cheng H, Yuan X, Sun X, Li K, Zhou Y, Yan D. Effect of degree of branching on the self-assembly of amphiphilic hyperbranched multiarm copolymers. Macromolecules 43, 1143-1147 (2010).
17. Zhang L, Lin J, Lin S. Aggregate morphologies of amphiphilic graft copolymers in dilute solution studied by self-consistent field theory. J. Phys. Chem. B 111, 9209-9217 (2007). (Pubitemid 47280520)
18. Qi H, Zhong C. Density functional theory studies on the microphase separation of amphiphilic comb copolymers in a selective solvent. J. Phys. Chem. B 112, 10841-10847 (2008).
19. Chandler D. Interfaces and the driving force of hydrophobic assembly. Nature 437, 640-647 (2005). (Pubitemid 41486526)
20. Antonietti M, Förster S. Vesicles and liposomes: a self-assembly principle beyond lipids. Adv. Mater. 15, 1323-1333 (2003).
21. Zhang L, Yu K, Eisenberg A. Ion-induced morphological changes in crew-cut aggregates of amphiphilic block copolymers. Science 272, 1777-1179 (1996).
22. Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug-delivery. Colloids Surf. B Biointerfaces 16, 3-27 (1999).
23. Kim D-W, Kim S-Y, Kim H-K, et al. Multicenter Phase II trial of Genexol-PM, a novel Cremophor®-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann. Oncol. 18, 2009-2014 (2007). (Pubitemid 350286241)
24. Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv. Drug Delivery Rev. 61, 768-784 (2009).
25. Matsumura Y. Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. Adv. Drug Del. Rev. 60, 899-914 (2008).
26. Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y. Block copolymer micelles as vehicles for drug-delivery. J. Control. Release 24, 119-132 (1993). (Pubitemid 23161325)
27. Kim JO, Kabanov AV, Tatiana BK. Polymer micelles with crosslinked polyanion core for delivery of a cationic drug doxorubicin. J. Control. Release 138, 197-204 (2009).
28. Bae Y, Fukushima S, Harada A, Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug-delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. 42, 4640-4643 (2003). (Pubitemid 37271305)
29. Christie RJ, Grainger DW. Design strategies to improve soluble macromolecular delivery constructs. Adv. Drug Delivery Rev. 55, 421-437 (2003). (Pubitemid 36293793)
30. Jang K-S, Lee HJ, Yang H-M, et al. Aqueous self-assembly of amphiphilic nanocrystallopolymers and their surface-active properties. Soft Matter 4, 349-356 (2008).
31. Saravanakumar G, Min KH, Min DS, et al. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. J. Control. Release 140, 210-217 (2009).
32. Tomida M, Nakato T, Matsunami S, Kakuchi T. Convenient synthesis of high molecular weight poly(succinimide) by acid-catalysed polycondensation of l-aspartic acid. Polymer 38, 4733-4736 (1997). (Pubitemid 127704536)
33. Kang HS, Yang SR, Kim J-D, Han S-H, Chang I-S. Effects of grafted alkyl groups on aggregation behavior of amphiphilic poly(aspartic acid). Langmuir 17, 7501-7506 (2001). (Pubitemid 35330983)
34. Yang SR, Jeong JH, Park K, Kim J-D. Self-aggregates of hydrophobically modified poly(2-hydroxyethyl aspartamide) in aqueous solution. Colloid Polym. Sci. 281, 852-861 (2003). (Pubitemid 37161616)
35. Jeong JH, Kang HS, Yang SR, Kim J-D. Polymer micelle-like aggregates of novel amphiphilic biodegradable poly(asparagine) grafted with poly(caprolactone). Polymer 44, 583-591 (2003). (Pubitemid 36083193)
36. Lee HJ, Yang SR, An EJ, Kim J-D. Biodegradable polymersomes from poly(2-hydroxyethyl aspartamide) grafted with lactic acid oligomers in aqueous solution. Macromolecules 39, 4938-4941 (2006).
37. Kang HS, Kim J-D, Han S-H, Chang I-S. Self-aggregates of poly(2-hydroxyethyl aspartamide) copolymers loaded with methotrexate by physical and chemical entrapments. J. Control. Release 81, 135-144 (2002). (Pubitemid 34454855)
38. Yang SR, Lee HJ, Kim J-D. Histidineconjugated poly(amino acid) derivatives for the novel endosomolytic delivery carrier of doxorubicin. J. Control. Release 114, 60-68 (2006). (Pubitemid 44144502)
39. Yang SR, Kim SB, Joe CO, Kim J-D. Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation. J. Biomed. Mater. Res. A 86, 137-148 (2007).
40. Discher BM, Won Y-Y, Ege DS, et al. Polymersomes: tough vesicles made from diblock copolymers. Science 284, 1143-1146 (1999). (Pubitemid 29288398)
41. Discher DE, Eisenberg A. Polymer vesicles. Science 297, 967-973 (2002). (Pubitemid 34856022)
42. LoPresti C, Lomas H, Massignani M, Smart T, Battaglia G. Polymersomes: nature inspired nanometer sized compartments. J. Mater. Chem. 19, 3576-3590 (2009).
43. Ben-Haim N, Broz P, Marsch S, Meier W, Hunziker P. Cell-specific integration of artificial organelles based on functionalized polymer vesicles. Nano Lett. 8, 1368-1373 (2008).
44. Bermudez H, Brannan AK, Hammer DA, Bates FS, Discher DE. Molecular weight dependence of polymersome membrane structure, elasticity, and stability. Macromolecules 35, 8203-8208 (2002). (Pubitemid 35173635)
45. Battaglia G, Ryan AJ. Bilayers and interdigitation in block copolymer vesicles. J. Am. Chem. Soc. 127, 8757-8764 (2005). (Pubitemid 40872231)
46. Ahmed F, Pakunlu RI, Srinivas G, et al. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol. Pharmaceutics 3, 340-350 (2006). (Pubitemid 44021440)
47. Koide A, Kishimura A, Osada K, Jang W-D, Yamasaki Y. Kataoka K. Semipermeable polymer vesicle (PICsome) self-assembled in aqueous medium from a pair of oppositely charged block copolymers: physiologically stable micro-/nanocontainers of water-soluble macromolecules. J. Am. Chem. Soc. 128, 5988-5989 (2006).
48. Kishimura A, Liamsuwan S, Matsuda H, et al. pH-dependent permeability change and reversible structural transition of PEGylated polyion complex vesicles (PICsomes) in aqueous media. Soft Matter 5, 529-532 (2009).
49. Kishimura A, Koide A, Osada K, Yamasaki Y, Kataoka K. Encapsulation of myoglobin in PEGylated polyion complex vesicles made from a pair of oppositely charged block lonomers: a physiologically available oxygen carrier. Angew. Chem. Int. Ed. 46, 6085-6088 (2007). (Pubitemid 47290959)
50. Yamaoka T, Tabata Y, Ikada Y. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 83, 601-606 (1994). (Pubitemid 24222392)
51. Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug 6, 193-210 (1989). (Pubitemid 20065994)
52. Yuan F, Dellian M, Fukumura D. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55, 3752-3756 (1995).
53. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Delivery Rev. 60, 1615-1626 (2008).
54. Bae Y, Nishiyama N, Kataoka K. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjugate Chem. 18, 1131-1139 (2007). (Pubitemid 47122634)
55. Dechantsreiter MA, Planker E, Matha B, et al. N-methylated cyclic RGD peptides as highly active and selective avb3 integrin antagonists. J. Med. Chem. 42, 3033-3040 (1999). (Pubitemid 29384038)
56. Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl Acad. Sci. USA 103, 6315-6320 (2006).
57. Hoffman AS. The origins and evolution of controlled drug-delivery systems. J. Control. Release 132, 153-163 (2008).
58. Jain RK, Munn LL, Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2, 266-276 (2002). (Pubitemid 37328780)
59. Nishiyama N, Nori A, Malugin A, Kasuya Y, Kope?ková P, Kopeek J. Free and N-(2-hydroxypropyl)methacrylamide copolymerbound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells. Cancer Res. 63, 7876-7882 (2003). (Pubitemid 37466722)
60. Koo AN, Lee HJ, Kim SE, et al. Disulfidecross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug-delivery. Chem. Commun. 6570-6572 (2008).
61. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
62. West KR, Otto S. Reversible covalent chemistry in drug-delivery. Curr. Drug Discov. Technol. 2, 123-160 (2005).
63. Bae Y, Nishiyama N, Fukushima S, Koyama H, Matsumura Y, Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjugate Chem. 16, 122-130 (2005). (Pubitemid 40129685)
64. Nasongkla N, Shuai X, Ai H, et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew. Chem. Int. Ed. 43, 6323-6327 (2004). (Pubitemid 40029462)
65. Oba M, Fukushima S, Kanayama N, et al. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing avb3 and avb5 integrins. Bioconjugate Chem. 18, 1415-1423 (2007).
66. Willmann JK, Van Bruggen N, Dinkelborg LM, Gambhir SS. Molecular imaging in drug development. Nat. Dev. Drug Discov. 7, 591-607 (2008). (Pubitemid 351927724)
67. Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 3, 1840-1854 (2007). (Pubitemid 350099850)
68. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat. Dev. Drug Discov. 2, 123-131 (2003). (Pubitemid 37361644)
69. Sun S, Zeng H, Robinson DB, et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J. Am. Chem. Soc. 126, 273-279 (2004).
70. Lee J-H, Huh Y-M, Jun Y-W, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13, 95-99 (2007). (Pubitemid 46067392)
71. Khemtong C, Kessinger CW, Gao J. Polymeric nanomedicine for cancer MR imaging and drug-delivery. Chem. Commun. 24, 3497-3510 (2009).
72. Kumagai M, Imai Y, Nakamura T, et al. Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloid. Surface. B. 56, 174-181 (2007). (Pubitemid 46467334)
73. Yang J, Lee C-H, Ko H-J, et al. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Angew. Chem. Int. Ed. 46, 8836-(2007).
74. Nasongkla N, Bey E, Ren JM, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug-delivery systems. Nano Lett. 6, 2427-2430 (2006). (Pubitemid 46076928)
75. Khemtong C, Kessinger CW, Ren J, et al. In vivo off-resonance saturation magnetic sesonance imaging of avb3-targeted superparamagnetic nanoparticles. Cancer Res. 69, 1651-1658 (2009).
76. Lee HJ, Jang K-S, Jang S, et al. Poly(amino acid)s micelle-mediated assembly of magnetite nanoparticles for ultra-sensitive long-term MR imaging of tumors. Chem. Commun. 46, 3559-3561 (2010).
77. Yang H-M, Lee HJ, Jang K-S, et al. Poly(amino acid)-coated iron oxide nanoparticles as ultra-small magnetic resonance probes. J. Mater. Chem. 19, 4566-4574 (2009).
78. Hamad I, Moghimi SM. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug. Expert Opin. Drug Del. 5, 205-219 (2008). (Pubitemid 351308312)
79. Kano MR, Bae Y, Iwata C, et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-b signaling. Proc. Natl Acad. Sci. USA 104, 3360-3465 (2007).